West Pharmaceutical Services ($WST) Insider Trading & Smart Money Activity

West Pharmaceutical Services, Inc. · Medical Instruments & Supplies · Latest filing Oct 13, 2026

West Pharmaceutical Services, Inc. ($WST) has 4 13F position changes and 3 analyst ratings on file.

Insider buyers (12 mo)
0
Insider sellers (12 mo)
0
Net insider $ (12 mo)
$0
Congress trades (12 mo)
0
13F moves on file
4
Analyst ratings on file
3

WST insider buying and selling by quarter

QuarterInsider buysInsider salesCongress buys / sales13F added / cut
Q1 2026 0 0 0 / 0 0 / 0
Q2 2026 0 0 0 / 0 2 / 2
Q3 2026 0 0 0 / 0 0 / 0
Q4 2026 0 0 0 / 0 0 / 0

Insider buys and sales count open-market trades only (Form 4 codes P and S). Grants, option exercises and tax withholding are left out.

All WST insider, congress, 13F and analyst activity

DateSourceWhoActionSharesValue / amount ΔOwn1W1M6MFilingStory
Analyst TD Cowen Reiterates to Buy PT $420 Read
Analyst Barclays Reiterates to Overweight PT $440 +2.2% —
Analyst Morgan Stanley Raises to Overweight PT $400 +1.5% —
13F Generation Investment Management Added +682.11K sh $805.59M +5.3%+10.4% —
13F Epoch Investment Partners Added +39.74K sh $195.67M +5.3%+10.4% —
13F Artisan Partners Limited Partnership Reduced -192.51K sh $885.85M +1.0%+8.7% —
13F Artisan Partners Limited Partnership Reduced -192.51K sh $954.18M +1.0%+8.7% —

1W / 1M / 6M = how WST moved from the trade or filing date.

Institutions moving WST (13F)

Analyst ratings on WST

DateFirmActionRatingPrice target1W1M6MStory
TD Cowen Reiterates Buy $410 → $420 Read
Barclays Reiterates Overweight $400 → $440 +2.2% —
Morgan Stanley Raises Overweight $365 → $400 +1.5% —

Frequently asked questions

Which institutions changed their WST positions?

Recent 13F filers moving the stock include Artisan Partners Limited Partnership, Generation Investment Management and Epoch Investment Partners.

Other medical instruments & supplies stocks

Data comes from public SEC Form 4 and 13F filings and STOCK Act disclosures. Dates are the trade or filing date reported. This page is for research only and is not investment advice.

Get trade alerts by text